Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

Characterization of s100 proteins of murine melanomas

Ivan Melezinek, Jan Borovansky, Milan Elleder

Med Sci Monit 1999; 5(5): BR828-832 :: ID: 503254

Abstract

S100 proteins are used as markers for human melanoma cells. They have been studied also in various animal models including even exotic melanomas but their biochemical characterization in B16 and CloudmanS91 murine melanomas, common models of human melanoma disease, has been still lacking. Histoimmuno chemical analysis showed its presence in B16 and S91 melanomas grown in inbred C57BL6J and DBA2 mice, respectively. The immunochemical dot-blot technique revealed that the S100 level was more than an order lower compared with human brain. S100 proteins were purified from murine melanomas and for comparison also from human brain. Disc polyacrylamide electrophoresis demonstrated the presence both of S100a and S100b subunits. Their molecular weight determined by means of SDS-PAGE was found to be 10 000 whereas the molecular weight of the whole S100 dimer (studied by gel filtration) was 21 000 and did not differ from that of S100 protein from human brain. Incubation of S100 isolated from human brain with autooxidating L-DOPA did not change its electrophoretic mobility. Polyclonal antibody against bovine brain S100 gave positive reaction with S100 proteins of murine melanomas and human brain origin. The identity of biochemical and immunological properties of the S100 proteins studied underlines the phylogenetic conservation of S100 structure and its stability even during tumour transformation.

Keywords: B16 melanoma, S100 protein, S91 melanoma

Comments

Editorial

04 June 2022 : Editorial  

Editorial: Acute Hepatitis of Unknown Origin in Children. Is Autoimmunity at Play?

Nahum Mendez-Sanchez, Shreya C. Pal
Faculty of Medicine, National Autonomous University of Mexico, Mexico City, Mexico

DOI: 10.12659/MSM.937371

Med Sci Monit 2022; 28:e937371

In Press

23 Jun 2022 : Clinical Research  

A Real-World Study to Compare the Safety and Efficacy of Paritaprevir/Ombitasvir/Ritonavir and Dasabuvir, w...

Med Sci Monit In Press; DOI: 10.12659/MSM.936706  

22 Jun 2022 : Clinical Research  

A Single-Center Study Comparing the Effects of Thoracic Spine Manipulation vs Mobility Exercises in 26 Offi...

Med Sci Monit In Press; DOI: 10.12659/MSM.937316  

21 Jun 2022 : Clinical Research  

Optimal Timing and Outcomes of Minimally Invasive Approach in Acute Biliary Pancreatitis

Med Sci Monit In Press; DOI: 10.12659/MSM.937016  

16 Jun 2022 : Clinical Research  

Renal Manifestations in Inflammatory Bowel Disease: A Cohort Study During the Biologic Era

Med Sci Monit In Press; DOI: 10.12659/MSM.936497  

Most Viewed Current Articles

30 Dec 2021 : Clinical Research  

Retrospective Study of Outcomes and Hospitalization Rates of Patients in Italy with a Confirmed Diagnosis o...

DOI :10.12659/MSM.935379

Med Sci Monit 2021; 27:e935379

08 Mar 2022 : Review article  

A Review of the Potential Roles of Antioxidant and Anti-Inflammatory Pharmacological Approaches for the Man...

DOI :10.12659/MSM.936292

Med Sci Monit 2022; 28:e936292

01 Nov 2020 : Review article  

Long-Term Respiratory and Neurological Sequelae of COVID-19

DOI :10.12659/MSM.928996

Med Sci Monit 2020; 26:e928996

01 Jan 2022 : Editorial  

Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...

DOI :10.12659/MSM.935952

Med Sci Monit 2022; 28:e935952

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750